BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32833496)

  • 1. Insurance Status in Rectal Cancer is Associated With Age at Diagnosis and May be Associated With Overall Survival.
    Bridges LC; Honaker MD; Smith BE; Montgomery A
    Am Surg; 2021 Jan; 87(1):105-108. PubMed ID: 32833496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment.
    Pulte D; Jansen L; Brenner H
    Oncologist; 2017 Mar; 22(3):351-358. PubMed ID: 28220019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and insurance status as risk factors for trauma mortality.
    Haider AH; Chang DC; Efron DT; Haut ER; Crandall M; Cornwell EE
    Arch Surg; 2008 Oct; 143(10):945-9. PubMed ID: 18936372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
    Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
    Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Socioeconomic Disparities After Surgical Resection for Rectal Cancer.
    Ghaffarpasand E; Welten VM; Fields AC; Lu PW; Shabat G; Zerhouni Y; Farooq AO; Melnitchouk N
    J Surg Res; 2020 Dec; 256():449-457. PubMed ID: 32798992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
    Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
    World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 16. Residual treatment disparities after oncology referral for rectal cancer.
    Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
    J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.